Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer

By sjmartinez • August 15, 2023

Wu TC, Stube A, Felix C, Oseguera D, Romero T, Goldman J, Garon EB, Lee JM, Glaspy J, Lisberg AE, Rusthoven CG, Camidge DR, Siva S, Solomon B, Lee A, Tenn SE, Shaverdian N, Steinberg ML, Raldow AC, Lee P. Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):118-122. doi: 10.1016/j.ijrobp.2023.03.069. Epub 2023 Apr 5. PMID: 37023987.

Tags: General Internal Medicine, Hematology/Oncology, Publications

Case Report: Exercise-associated changes of leukocyte gene expression in statin-associated myopathy

Bondar G, Mahapatra AD, Silacheva I, Bao TM, Vu T, Su S, Hairapetian A, Katappagari A, Galan L, Chandran J, Adamov R, Yang A, Bukkapatnam[...]

A Case of Otomyiasis in an Intoxicated Patient

Tran AT, Lee DT, Maque J. A Case of Otomyiasis in an Intoxicated Patient. Cureus. 2025 Nov 20;17(11):e97352. doi: 10.7759/cureus.97352. PMID: 41426897; PMCID: PMC12718086.

Stakeholder input on the CAHPS ambulatory surveys

Hays RD, Brown JA, Bianculli E, Elliott M. Stakeholder input on the CAHPS ambulatory surveys. J Patient Rep Outcomes. 2025 Dec 22. doi: 10.1186/s41687-025-00983-1. Epub[...]